# Vyepti

NDC: 67386-130
Generic name: eptinezumab-jjmr
Labeler / Manufacturer: Lundbeck Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200221

FDA application: BLA761119

## Active ingredients

- EPTINEZUMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67386-130"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67386-130
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79065861-6aa5-4d1f-829f-3a6471286b36